Continuing Education Activity
Perianal streptococcal dermatitis is a cellulitis of the perineum. The most common causative organism is group A beta-hemolytic streptococci. Therefore, perianal streptococcal dermatitis is treated with both oral and topical antimicrobials. This dermatologic condition is a disease of children and often presents in the winter and spring months. This activity reviews the evaluation and management of perianal streptococcal dermatitis and highlights the role of the interprofessional team in evaluating and treating patients with this condition.
Objectives:
Identify the etiology and epidemiology of perianal streptococcal dermatitis.
Describe the physical exam findings associated with perianal streptococcal dermatitis.
Outline the treatment considerations for patients with perianal streptococcal dermatitis.
Summarize the importance of improving care coordination among the interprofessional team to improve outcomes for patients affected by perianal streptococcal dermatitis.
Access free multiple choice questions on this topic.
Introduction
Perianal streptococcal dermatitis is an infectious dermatologic disease that typically affects children between the ages of 6 months and 10 years old. The disease is more properly characterized as cellulitis because the most common causative agent is group A beta-hemolytic streptococci. Perianal streptococcal dermatitis classically presents as perianal erythema with well-defined margins. Superficial erosions, anal fissures, excoriations, and purulent discharge may also be present. Clinicians can make a definitive diagnosis with a bacterial culture after swabbing the lesion. A combination of oral antibiotics and topical antiseptics is the treatment of choice. The diagnosis of perianal streptococcal dermatitis should merits consideration when encountering a child who has changes in bowel movements and perineal complaints.[1][2][3]
Etiology
Perianal streptococcal dermatitis (PSD) is a slight misnomer. The term dermatitis is used to describe an irritated and inflamed epidermis. While an irritated epidermis is observable with PSD, the disease is actually most commonly caused by the infection of group A beta-hemolytic streptococci (GABHS). Therefore, PSD is more correctly a variant of cellulitis rather than dermatitis.[1][4]
Epidemiology
The most common age group affected by perianal streptococcal dermatitis are patients between the ages of 6 months and 10 years old. Males are more commonly affected than females with a ratio between 3 to 1 and 2 to 1. Interestingly, patients are more commonly affected in the winter and spring months. While perianal streptococcal dermatitis is typically thought to be a pediatric disease, there have been case reports in adults.[1][4]
Pathophysiology
Perianal streptococcal dermatitis classifies as cellulitis most commonly caused by GABHS. There are multiple hypotheses about the mode of infection of the perineum by GABHS. One hypothesis proposes the autoinoculation of the perineal tissues by digital contact with the oral cavity, nasal cavity, and perineum. Patients transfer the bacteria to the perineum either by direct digital contact or by swallowing the bacteria. This hypothesis garners support from the fact that 92% of PSD diagnoses had concomitant pharyngeal GABHS. There is also a belief that fomites could play a role in the transmission of GABHS to cause PSD. Previous studies have found there is a higher occurrence within families and daycare centers. Some attribute the higher occurrence rates to shared surfaces such as toilet seats or bathtubs.[1]
History and Physical
A complete history and physical exam are integral to the accurate and timely diagnosis of perianal streptococcal dermatitis. History from the pediatric patient needs includes the parents. Spending time to conduct a precise history and physical exam will lead the physician to a relatively straightforward diagnosis. Clinicians should have a high index of suspicion for the diagnosis of PSD with any child who has perineal pain and changes in bowel habits.
Typical symptoms of perianal streptococcal dermatitis include:
For the diagnosis of PSD, the anus, perineum, and genitalia require examination. PSD classically presents with varying degrees of perianal erythema with well-defined margins. Superficial erosions, anal fissures, excoriations, and purulent discharge may also be present. Once the clinician considers a diagnosis of PSD, definitive tests are necessary.[2][1][3][5]
Evaluation
For a definitive diagnosis of perianal streptococcal dermatitis, bacterial swabs are necessary from the affected areas; ideally of the exudate. The swabs will be sent for culture to confirm the growth of GABHS.[1] Blood tests such as anti-streptolysin O antibodies and anti-streptokinase titers have been deemed unreliable to diagnose PSD.[6] Finally, a urinalysis should be obtained to monitor for post-streptococcal glomerulonephritis during follow-up appointments.[1]
Treatment / Management
After making the diagnosis of perianal streptococcal dermatitis, treatment is relatively straightforward. In minor cases of the disease, some sources recommend treating PSD with topical antimicrobials. However, oral antibiotics are the recommended first-line treatment of the disease. The most successful treatment regimens utilize a combination of systemic and topical antibiotics. Systemic antibiotics include penicillin V, erythromycin, azithromycin, clarithromycin, clindamycin, penicillinase-resistant penicillin, or cephalosporins. These oral antibiotics work best in conjunction with a topical antiseptic such as chlorhexidine, or an antibiotic such as mupirocin. Treatment duration is for 14 to 21 days, and perianal swabs and culture should be taken to ensure eradication of the bacteria.[1][7]
Differential Diagnosis
The following differential diagnoses merit consideration[1][8]:
Irritant dermatitis - heavy wiping or manipulation
Candidiasis
Seborrheic dermatitis
Atopic dermatitis
Psoriasis
Allergic contact dermatitis
Pinworm infection
Inflammatory bowel disease
Histiocytosis
Sexual abuse
Prognosis
With proper antibiotic use, perianal streptococcal dermatitis usually resolves within 14 to 21 days. However, there is a chance for recurrence due to children's poor hygiene and habitual behaviors.[9] Pediatric patients and their parents need to be counseled on proper hand hygiene and breaking the process of autoinoculation.
Complications
Prolonged discomfort due to delayed diagnosis and treatment is the leading complication of perianal streptococcal dermatitis. There are also extremely rare cases, such as proctitis and abscess formation, caused by concurrent PSD. A prolonged disease course also increases the risk of bacterial transmission to close contacts, particularly siblings and parents. Rheumatic fever is a theoretical complication of PSD. However, there are no case reports published describing this sequela. Cellulitis caused by GABHS, including PSD, can cause post-streptococcal nephritis. Therefore, follow-up urinalysis is essential to monitor kidney function.[1][10]
Deterrence and Patient Education
Perianal streptococcal dermatitis is a rather simple dermatologic disease to treat. However, patient education is an absolutely essential piece of the treatment plan that often gets overlooked. Patients and their parents require counseling on the importance of follow-up appointments. A repeat perineal swab needs to be obtained to ensure complete eradication of GABHS. Performing this step will reduce the chance of PSD recurrence. During the follow-up appointment, a urine specimen also needs to be collected and sent for analysis to monitor for post-streptococcal nephritis. Finally, patients and families need to be educated on proper hygiene techniques to reduce the transmission of the causative organism.[1][10][9]
Enhancing Healthcare Team Outcomes
The management of rashes in the pediatric population requires an interprofessional team. There are many causes of rashes in infants, and the presentation is diverse. Thus, when in doubt, the primary care clinicians and nurses should refer these patients to a pediatrician or a dermatologist. Not all rashes that occur in the perineum area are due to candida and delays in diagnosis and treatment only lead to more morbidity.
Laboratory technicians need to be included in the healthcare team to enhance healthcare team outcomes while treating PSD. With routine perineal swabs, laboratories may plate the specimen on MacConkey agar in search of enteric stool pathogens. This medium will not grow GABHS and will miss the diagnosis of PSD. Therefore, the clinician needs to communicate with the laboratory to search for GABHS and ensure the laboratory plates the specimen on blood agar. This simple communication will minimize an unnecessary delay in identifying the causative organism and therefore, any delay in treatment.[11][1] [Level 5]
Nursing and pharmacy both play an essential role in the management of perianal streptococcal dermatitis. Nursing can administer medication and also counsel patients and parents about applying topical agents properly. The pharmacist can also consult on appropriate antimicrobial agent selection and also offer additional patient (parental) counseling on drug therapy. Both nursing and pharmacy need an open communication channel with the treating clinician to report any concerns they may have. Only with this type of open and collaborative interprofessional team approach can the management of perianal streptococcal dermatitis offer the best patient outcomes. [Level 5]
References
- 1.
Herbst R. Perineal streptococcal dermatitis/disease: recognition and management.
Am J Clin Dermatol. 2003;4(8):555-60. [
PubMed: 12862498]
- 2.
Lehman R, Pinder S. Streptococcal perianal infection in children.
BMJ. 2009 May 05;338:b1517. [
PubMed: 19416994]
- 3.
Palha MJ, Limão S, Santos MC, Cunha F. Perianal streptococcal dermatitis.
Pediatr Neonatol. 2019 Dec;60(6):691-692. [
PubMed: 31036462]
- 4.
Šterbenc A, Seme K, Lah LL, Točkova O, Kamhi Trop T, Švent-Kučina N, Pirš M. Microbiological characteristics of perianal streptococcal dermatitis: a retrospective study of 105 patients in a 10-year period.
Acta Dermatovenerol Alp Pannonica Adriat. 2016 Dec;25(4):73-76. [
PubMed: 28006879]
- 5.
Marks VJ, Maksimak M. Perianal streptococcal cellulitis.
J Am Acad Dermatol. 1988 Mar;18(3):587-8. [
PubMed: 3280624]
- 6.
Amren DP, Anderson AS, Wannamaker LW. Perianal cellulitis associated with group A streptococci.
Am J Dis Child. 1966 Dec;112(6):546-52. [
PubMed: 5928818]
- 7.
Petersen JP, Kaltoft MS, Misfeldt JC, Schumacher H, Schønheyder HC. Community outbreak of perianal group A streptococcal infection in Denmark.
Pediatr Infect Dis J. 2003 Feb;22(2):105-9. [
PubMed: 12586971]
- 8.
Jongen J, Eberstein A, Peleikis HG, Kahlke V, Herbst RA. Perianal streptococcal dermatitis: an important differential diagnosis in pediatric patients.
Dis Colon Rectum. 2008 May;51(5):584-7. [
PubMed: 18324440]
- 9.
Mempel M, Schnopp C. [Selected bacterial infections of the skin in childhood].
Hautarzt. 2015 Apr;66(4):252-7. [
PubMed: 25783212]
- 10.
Block SL. Perianal dermatitis: much more than just a diaper rash.
Pediatr Ann. 2013 Jan;42(1):12-4. [
PubMed: 23316826]
- 11.
Krol AL. Perianal streptococcal dermatitis.
Pediatr Dermatol. 1990 Jun;7(2):97-100. [
PubMed: 2359737]
Disclosure: Kevin Pennycook declares no relevant financial relationships with ineligible companies.
Disclosure: Tess McCready declares no relevant financial relationships with ineligible companies.
